skip to main |
skip to sidebar
BY RACHEL FELTMAN The Washington Post, May
22, 2015
It's been
a billion years since we shared a common ancestor, but yeast -- a simple,
single-celled fungus -- is still a distant cousin on our family tree. In fact,
even this distant relation has enough in common with us to swap out genes and
survive.
In a
study published Thursday in Science, researchers report successfully
swapping out some 450 of the genes in baker's yeast with similar ones from
a human. Each swapped gene got its own strain of yeast, so hundreds were
created. With about half of those swaps, the yeast survived as a human-yeast
hybrid.
Even
after a long evolutionary separation, humans and common yeast actually
have thousands of genes in common -- ones that seem to have the same biological
origin and serve the same purpose. To test just how similar those analogous
genes have stayed throughout the eons, the scientists swapped out the ones that
yeast truly needs in order to survive.
So the
fact that these hybrid yeasts survived shows just how closely related all
living things are. And yeast probably has hundreds more genes that it could
borrow from humans."Cells
use a common set of parts and those parts, even after a billion years of
independent evolution, are swappable," study author Edward
Marcotte of University of Texas Austin said in a statement. "It's a beautiful demonstration of
the common heritage of all living things -- to be able to take DNA from a human
and replace the matching DNA in a yeast cell and have it successfully support
the life of the cell."
Marcotte
and his colleagues also found out something about the key to a successful swap:
The actual similarity of the genes didn't seem to be a good indicator of
whether they'd keep the yeast alive. But if one gene from a particular module
-- a group of genes that work together -- was swappable, the rest of its module
likely was as well (and vice versa).The
scientists won't be creating gingerbread frankensteins anytime soon, but they
hope their yeast strains can be used to study how defective genes that cause
human disease react to different therapies.